The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: Implications for the development of metastatic disease

Endocrinology

Volumn 138, Issue 3, 1997, Pages 1145-1150

  Ritchie, Candace K ^a   Andrews, Laura R ^a   Thomas, Kris G ^a   Tindall, Donald J ^a   Fitzpatrick, Lorraine A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN B; SOMATOMEDIN C; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0031050633     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.3.4974     Document Type: Article

References (40)

1. Chiarodo A 1991 National Cancer Institute round table on prostate cancer: future research directions. Cancer Res 51:2498-2505
2. Glaves D 1987 Mechanisms of metastasis: prostate cancer Prog Clin Biol Res 239:329-345
3. Scher HI, Chung LWK 1994 Bone metastases: improving the therapeutic index. Semin Oncol 21:630-656
4. Ishibe M, Rosier RN, Puzas JE 1991 Human prostatic add phosphatase directly stimulates collagen synthesis and alkaline phosphatase content of isolated bone cells. J Clin Endocrinol Metab 73:785-792
5. Paget S 1889 The distribution of secondary growths in cancer of the breast Lancet 1:571-573
6. Fidler IJ 1990 Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50:6030-6138
7. Baylink DJ, Finkleman RD, Mohan S 1993 Growth factors to stimulate bone formation, J Bone Miner Res [Suppl 8] 2:S565-S572
8. Dodds RA, Merry K, Littlewood A, Gowen M 1994 Expression of mRNA for IL1 β, IL6 and TGF β in developing human bone and cartilage. J Histochem Cytochem 42:733-744
9. Ingram R, Bonde S, Riggs BL, Fitzpatrick LA 1994 Effects of transforming growth factor β (TGF β) and 1,23 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55:153-163
10. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB 1994 TGF β alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335
11. Panagakos FS 1993 Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria. Biochimie 75:991-994
12. Gabbitas B, Fash J, Canalis E 1994 Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology 135:284-289
13. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303
14. Chaudhary LR, Spelsberg TC, Riggs BL 1992 Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 β and tumor necrosis factor-α: lack of regulation by 17 β-estradiol. Endocrinology 130:2528-2534
15. Damoulis PD, Hauschka PV 1994 Cytokines induce nitric oxide production in mouse osteoblasts. Biochem Biophys Res Commun 201:924-931
16. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818
17. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF 1978 Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 21:274-281
18. Kaign ME, Narayan KS, Ohnuki Y, Lechner J, Jones LW 1979 Establishment and characterization of a human prostatic cancer cell line (PC-3). Invest Urol 17:16-23
19. Ritchie CK, Maercklein PB, Fitzpatrick LA 1994 Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations. Endocrinology 135:996-1003
20. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
21. Campbell PB 1977 An improved method for the in vitro evaluation of monocyte leukotaxis. J Lab Clin Med 90:381-388
22. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ 1982 Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227-230
23. Derynck R, Goeddel DV, Ullrich A, Guttenman JU, Williams RD, Bringman TS, Beryer WH 1987 Synthesis of messenger RNAs for transforming growth factors a and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712
24. Cohen P, Peehl DM, Lamson G, Rosenfeld RG 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407
25. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG 1993 Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:1031-1035
26. Iwamura M, Sluss PM, Casamento JB, Cockett ATK 1993 Insulin-like growth factor 1: action and receptor characterization in human prostate cancer cell lines. Prostate 22:243-252
27. Centrella M, McCarthy TL, Canalis E 1990 Receptor of insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 126:39-44
28. Pietrzowski Z, Wernicke D, Potcu P, Jameson A, Baserga R 1992 Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res 52:6447-6451
29. Figueroa JA, Lee AV, Jackson JG, Yee D 1995 Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine loop. J Clin Endocrinol Metab 80:3476-3482
30. Angelloz-Nicoud P, Binoux M 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492
31. Conover CA, Perry JE, Tindall DJ 1995 Endogenous cathepsin D-mediated hydrolysis of the insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 80:987-993
32. Schuurmans AL, Bolt J, Voorhorst M, Blankenstein RA, Mulder E 1989 Regulation of growth and epidermal growth factor receptor levels in LNCaP prostate tumor cells by different steroids. Int J Cancer 42:917-922
33. Sporn MB, Roberts A, Wakefeild LM, de Crombrugghe B 1987 Some recent advances in the chemistry and biology of transforming growth factor β. J Cell Biol 105:1039-1045
34. Connolly JM, Rose DP 1990 Production of transforming growth factor α by the androgen responsive LNCaP human prostate cancer cell line. Prostate 16:209-218
35. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E 1989 Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79-87
36. Tjota A, Zhang YQ, Piedmonte MR, Lee CL 1991 Adoptive immunotherapy using lymphokine-activared killer cells and recombinant interleukin-2 preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor. J Urol 146:177-183
37. Schuurmans AL, Bolt J, Veldscholte J, Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197
38. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I 1990 Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 50:7786-7788
39. Fruehauf JP, Sinha BK 1992 Selective formation of tumor necrosis factor-α (TNF) degradation products contributed to TNF mediated cytotoxicity. Oncol Res 4:91-101
40. Sherwood ER, Pitt Ford TR, Lee C, Kozlowski JM 1990 Therapeutic efficacy of recombinant tumor necrosis factor a in an experimental model of human prostatic carcinoma. J Biol Response Mod 9:44-52